Imidazoline receptor ligands:cardiovascular applications
- 1 June 1998
- journal article
- Published by Informa Healthcare in Emerging Drugs
- Vol. 3 (1), 113-120
- https://doi.org/10.1517/14728214.3.1.113
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Combined Sympathetic Suppression and Angiotensin-Converting Enzyme Inhibition in Congestive Heart FailureHypertension, 1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Imidazoline Receptors and Their Endogenous LigandsAnnual Review of Pharmacology and Toxicology, 1996
- Autonomic nervous system and sudden cardiac deathJournal of the American College of Cardiology, 1996
- The elusive family of imidazoline binding sitesTrends in Pharmacological Sciences, 1996
- Antiarrhythmic Effect of the Selective I1‐Imidazoline Receptor Modulator Moxonidine on Ouabain‐Induced Cardiac Arrhythmia in Guinea PigsAnnals of the New York Academy of Sciences, 1995
- Section Review—Cardiovascular & Renal: Recent Advances in Imidazoline Receptor ResearchExpert Opinion on Investigational Drugs, 1995
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Clonidine in congestive heart failure: A vasodilator with negative inotropic effectsThe American Journal of Cardiology, 1983